Login / Signup

A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer.

Alex CazesOscar BetancourtEdgar EsparzaEvangeline S MoseDawn JaquishEric M WongAlexis A WascherHervé TiriacMarco GymnopoulosAndrew M Lowy
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Together, these results suggest the promise of agents such as TR1801-ADC as a novel approach to the treatment of pancreatic cancer.
Keyphrases
  • cancer therapy
  • tyrosine kinase
  • big data
  • machine learning
  • computed tomography
  • diffusion weighted
  • radiation therapy
  • combination therapy
  • drug delivery
  • diffusion weighted imaging
  • artificial intelligence